Markie, I don't remember Pharmaxis taking out a loan?? The financing agreement that I believe you are referring too is nothing like maxing out on credit cards because it does not have to be paid back. And yes I thought it was pretty positive the fact that Novaquest was willing to pay $20 million for low single digit Bronchitol CF revenue from EU and US (for 8 and 7 years respectively). If you think its a bad move for Pharmaxis in a round-a-bout way you are saying Bronchitol for CF for EU and US is worth north of $400 million. Seems strange then that you have a sell sentiment when the company is valued at $100 million.
9year low..., page-53
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SNT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $36.13M | |||
| Open | High | Low | Value | Volume |
| 2.9¢ | 3.0¢ | 2.8¢ | $145.4K | 5.129M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 1763138 | 2.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.8¢ | 235590 | 1 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| SNT (ASX) Chart |